20:58 , Jun 13, 2019 |  BC Innovations  |  Finance

Sitting it out: Why some investors are staying out of mega-series A rounds

As series A rounds continue to balloon, some VCs are opting to stay away from super-sized rounds, arguing the large boluses of cash up front can erode financial discipline and constrain exit options, hurting returns....
00:17 , Sep 15, 2018 |  BioCentury  |  Finance

Hua’s institutional advantage

The same market forces that drove Hua Medicine Ltd. to reduce the size of its Hong Kong IPO tempered participation by retail investors, which could help keep the Shanghai diabetes company’s share price steady amidst...
19:16 , Sep 14, 2018 |  BC Week In Review  |  Financial News

Hua raises $110.5M in HK IPO, trades flat on first day

Hua Medicine Ltd. (HKSE:2552) shares ended the day unchanged at HK$8.28 in the company's first day of trading Sept. 14. The diabetes play raised HK$867 million ($110.5 million) in an IPO through the sale of...
17:43 , Sep 13, 2018 |  BC Extra  |  Financial News

Hua raises $110M in Hong Kong IPO

Diabetes company Hua Medicine Ltd. (HKSE:2552) raised HK$867 million ($110.5 million) in an IPO through the sale of 104.8 million shares at HK$8.28. EVP and CFO George Lin said the offering, which priced at the...
01:18 , May 12, 2018 |  BioCentury  |  Finance

HKEX opportunity knocking

The rapid growth of biotech in the greater China region is something Jefferies does not intend to miss. With the opening of a new biotech chapter on the Hong Kong Exchanges and Clearing Ltd. on...
22:19 , Mar 16, 2018 |  BioCentury  |  Finance

Hong Kong’s new chapter

Introducing a biotech chapter to the Hong Kong stock exchange fills a massive void in the region’s innovation ecosystem, but won’t come without risks. It promises to create a long sought public capital market for...
07:00 , Sep 27, 2016 |  BC Extra  |  Financial News

Color Genomics raises $45M in series B

Diagnostic company Color Genomics Inc. (Burlingame, Calif.) raised $45 million in a series B round led by General Catalyst. Singer-songwriter Bono also participated, as did existing investors Susan Wagner, 8VC, Kholsa Ventures and Emerson Collective....
07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

Corvus Pharmaceuticals completes venture financing

Corvus Pharmaceuticals Inc. , Burlingame, Calif.   Business: Cancer   Date completed: 2015-09-29   Type: Venture financing   Raised: $75 million   Investors: Rock Springs Capital; Fidelity; BlackRock; T. Rowe Price; Jennison Associates; Roche Venture...
01:05 , Sep 30, 2015 |  BC Extra  |  Financial News

Corvus raises $75M in series B round

Corvus Pharmaceuticals Inc. (Burlingame, Calif.) raised $75 million in a series B round led by new investor Rock Springs Capital Management. New investors Fidelity; Blackrock; T. Rowe Price; Jennison Associates; Roche Venture Fund; Cormorant Asset...
07:00 , Aug 3, 2015 |  BioCentury  |  Finance

General trickle

Although biotech indices have advanced at least 2% this quarter and are frequently touching new highs, Paul Yook of LifeSci Capital expects the sector has more room to run. The reason, he said, is generalist...